An announcement from Surgery Partners ( ($SGRY) ) is now available. On August 13, 2025, Surgery Partners, Inc. announced a second amendment to its ...

Explore Surgery Partners' Q2 2025 performance with $826M revenue & 9% EBITDA growth. Learn about M&A strategy, leadership changes, & market outlook.

Q2 2025 Earnings Call Transcript August 5, 2025 Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.3363, expectations were $0.16. Operator: Good day, and welcome to the Surgery ...

On a per-share basis, the Brentwood, Tennessee-based company said it had a loss of 2 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 17 cents per share. The results ...

Reaffirms Full Year 2025 Guidance BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ('Surgery Partners” or the 'Company”), a leading short-stay surgical facility ...

Brentwood, Tenn.-based Surgery Partners is doubling down on independence following the decision not to proceed with Bain Capital’s proposed acquisition, according to the company’s second quarter ...

Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 4.3% in the morning session after Bank of America Securities resumed coverage on the stock with a 'Buy' rating and a $28 price target ...

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) in the first quarter, according to its most recent disclosure ...

Surgery Partners reaffirmed its full-year 2025 guidance, projecting revenue between $3.30 billion and $3.45 billion and Adjusted EBITDA between $555 million and $565 million. The midpoint of the ...

Bank of America initiated coverage on shares of Surgery Partners (NASDAQ:SGRY – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “buy ...

UnitedHealth Group has announced the appointment of Wayne DeVeydt, former CEO of ASC chain Surgery Partners, as its new chief financial officer, effective September 2. Here are three points to know: 1 ...

Investing.com - BofA Securities resumed coverage of Surgery Partners (NASDAQ:SGRY) with a Buy rating and a price target of $28.00 on Monday. According to InvestingPro data, this target aligns with ...